Clinical results of implanted tissue engineered heart valves

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Surgery

Background:

• Biological heart valves have evolved since 1955, with allografts and xenografts undergoing various preservation and fixation methods.
• Current methods like glutaraldehyde fixation for xenografts cause structural deterioration and result in non-viable tissues.
• Existing bioprostheses lack the crucial capabilities of remodeling, regeneration, and growth.

Purpose of the Study:

• To explore tissue engineering as a method to overcome limitations of current biological heart valves.
• To outline key strategies for developing living, functional autologous heart valves.
• To review initial clinical outcomes of tissue-engineered heart valves.

Main Methods:

• Utilizing appropriate scaffolds to support cell growth in vitro or in vivo.
• Engineering scaffolds that facilitate cell proliferation and extracellular matrix deposition.
• Developing a process for in vivo remodeling into a functional autologous heart valve.

Main Results:

• Tissue engineering provides living bioprostheses with potential for remodeling, regeneration, and growth.
• Scaffold-based approaches enable the development of neo-tissue that mimics native heart valve structure and function.
• Initial clinical results indicate the feasibility of tissue-engineered heart valves.

Conclusions:

• Tissue engineering represents a significant advancement over traditional bioprostheses.
• Developing living, autologous heart valves addresses limitations of non-viable, non-regenerative current options.
• The creation of functional, tissue-engineered heart valves shows promise for future clinical applications.